SCHEMBL4472197

SCHEMBL4472197

Cc1cc(C)c2c(C#N)c(C=O)n(CC3CCCO3)c2n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.46
KDM4E B2RXH2 8/20 0.43
GLA P06280 7/20 0.43
HPGD P15428 6/20 0.43
GAA P10253 5/20 0.43
HSD17B10 Q99714 6/20 0.42
CASP1 P29466 4/20 0.42
CASP7 P55210 4/20 0.42
KMT2A Q03164 3/20 0.42
MEN1 O00255 2/20 0.42
HTT P42858 3/20 0.41
POLB P06746 1/20 0.41
HIF1A Q16665 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
TSHR P16473 4/20 0.41
MAPT P10636 1/20 0.40
ATM Q13315 1/20 0.39
PIK3CA P42336 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
CYP1A2 P05177 4/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4481858 0.86 MAPT (0.43) ALDH1A1KDM4EGLAHPGDGAA
SCHEMBL4481853 0.86 MAPT (0.43) ALDH1A1KDM4EGLAHPGDGAA
SCHEMBL4481338 0.82 ALDH1A1 (0.38) ALDH1A1KDM4EGLAHPGDGAA
SCHEMBL4481344 0.82 ALDH1A1 (0.38) ALDH1A1KDM4EGLAHPGDGAA
SCHEMBL4487856 0.77 ALDH1A1 (0.43) ALDH1A1KDM4EGLAHPGDGAA
SCHEMBL4487864 0.77 ALDH1A1 (0.43) ALDH1A1KDM4EGLAHPGDGAA
SCHEMBL4480682 0.77 KMT2A (0.35) ALDH1A1KDM4EGLAHPGDGAA
SCHEMBL4480675 0.77 KMT2A (0.35) ALDH1A1KDM4EGLAHPGDGAA
SCHEMBL4477559 0.75 ALDH1A1 (0.46) ALDH1A1KDM4EGLAHPGDGAA
SCHEMBL4470476 0.74 HPGD (0.55) ALDH1A1KDM4EGLAHPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7582651-B2 Pyrrolopyridine derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-09-01 US disclosed
US-20060167038-A1 Pyrrolopyridine derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-07-27 US disclosed
EP-1535922-A1 PYRROLOPYRIDINE DERIVATIVE AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2005-06-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060167038-A1 Pyrrolopyridine derivative and use thereof OPRD1, TRPV1, OPRM1 ALDH1A1 1363/4885KDM4E 2991/4885GLA 4799/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.